Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also
intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is based in Miami Beach, Florida. The company trades on NCM exchange. The company headquarter is located in Miami Beach ,United States.
| Ticker | KTTA |
| Long Name | Pasithea Therapeutics Corp. |
| Short Name | Pasithea Therapeutics Corp. |